Warning letters, 483s, Recalls, Import Alerts, Audit observations
Indian API manufacturer Jagsonpal Pharmaceuticals was issued a Warning Letter by the US FDA in
Chinese OTC Manufacturer Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd was inspected by USFDA in March
FDA has issued final guidance on Circumstances that constitute Delaying, Denying, Limiting, or Refusing a
The letter to FDA was written by the Republican members of the E&C committee of
In an Interview to CNBCTV18 during visit to India, USFDA Commissioner touched on different topics
